Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 1, 1998, Pages 46-52

  Berntsen, Hildegunn ^a   Lønning, Per Eystein ^a   Ekse, Dagfinn ^a   Netteland, Bjørn ^a   Johannessen, Dag Clement ^a   Berge, Rolf ^a   Svardal, Asbjørn ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Glutamyl transpeptidase; Aminoglutethimide; Breast cancer; Glutathione; Reduction and oxidation

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE INHIBITOR; DEXAMETHASONE; EXEMESTANE; FORMESTANE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HYDROCORTISONE ACETATE; THIOL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PLASMA; PRIORITY JOURNAL;

AGED; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; DEXAMETHASONE; ENZYME INHIBITORS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED;

EID: 0031956773     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050783     Document Type: Article

References (28)

1. Andersson A, Lindgren A, Hultberg B (1995) Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem 41: 361
2. Bard S, Noël P, Chauvin F, Quash G (1986) γ-Glutamyl-transpeptidase activity in human breast lesions: an unfavourable prognostic sign. Br J Cancer 53: 637
3. Brown BA (1993) Hematology: principles and procedures. Lea & Febiger, Philadelphia
4. Edwards CJ, Fuller J (1996) Oxidative stress in erythrocytes. Comp Haematol Int 6: 24
5. Hanigan MH (1995) Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 16: 181
6. Johnson RA, Wichern DW (1982) Applied multivariate statistical analysis. Prentice-Hall, Englewood Cliffs
7. Kondo T, Dale GL, Beutler E (1995) Thiol transport from human red blood cells. Methods Enzymol 252: 72
8. Lewis AD, Hayes JD, Wolf CR (1988) Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis 9: 1283
9. Lønning PE (1990) Aminoglutethimide enzyme induction: pharmacological and endocrinological implications. Cancer Chemother Pharmacol 26: 241
10. Lønning PE (1996) Pharmacology of new aromatase inhibitors. Breast 5: 202
11. Lønning PE, Kvinnsland S (1988) Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs 35: 685
12. Loønning PE, Wiedemann G, Kvinnsland S, Lundgren S (1988) Welche Hormontherapie bei fortgeschrittenem Mammakarzinom des Mannes. Dtsch Med Wochenschr 113: 1358
13. Magnani M, Novelli G, Palloni R (1984) Human plasma glutathione oxidation in normal and pathological conditions. Clin Physiol Biochem 2: 287
14. Mansoor MA, Svardal AM, Ueland PM (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocystine, and glutathione in human plasma. Anal Biochem 200: 218
15. Meister A (1995) Glutathione metabolism. Methods Enzymol 251: 3
16. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711
17. Meyts ER-D, Shi M, Chang M, Robinson TW, Groffen J, Heisterkamp N, Forman HJ (1992) Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione. Toxicol Appl Pharmacol 114: 56
18. Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G (1995) Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem 41: 1509
19. Mulders TMT, Keizer HJ, Breimer DD, Mulder GJ (1995) In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients. Drug Metab Rev 27: 191
20. Munday R, Winterbourn CC (1989) Reduced glutathione in combination with Superoxide dismutase as an important biological antioxidant defence mechanism. Biochem Pharmacol 38: 4349
21. Murray M, Cantrill E, Farrell GC (1993) Induction of cytochrome P450 2B1 in rat liver by the aromatuse inhibitor aminoglutethimide. J Pharmacol Exp Ther 265: 477
22. Nagel GA, Wander H-E, Blossey H-C (1982) Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res 42: 3442
23. O'Brien ML, Tew KD (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A: 967
24. Ohnhaus EE, Park BK (1979) Measurement of urinary 6-B-hydrocortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 15: 139
25. Schröder CP, Godwin AK, O'Dwyer PJ, Tew KD, Hamilton TC, Ozols RF (1996) Glutathione and drug resistance. Cancer Invest 14: 158
26. Svardal AM, Mansoor MA, Ueland PM (1990) Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 184: 338
27. Technicon Instruments Corporation (1990) Technicon method no. SA-40308.90, GGT. Technicon Instruments Corporation, Tarrytown, New York
28. Whitfield JB, Moss DW, Neale G, Orme M, Breckenridge A (1973) Changes in plasma γ-glutamyl transpeptidase activity associated with alterations in drug metabolism in man. BMJ 1: 316